SPONSOR
Neurocrine Biosciences
Total Trials
2
Recruiting
2
Phases
Phase 2
NCT07187375 Phase 2
Recruiting
Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years Old
Congenital Adrenal Hyperplasia
NCT07288320 Phase 2
Recruiting
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
Bipolar I Disorder